|
|
|
|
Vol. 16, Issue 10, 4672-4683, October 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




* National Research Laboratory for Cancer Epigenetics, Cancer Research Institute, Seoul National University College of Medicine, Seoul, 110-799, Korea;
Department of Internal Medicine, Seoul National University College of Medicine, Seoul 110-744, Korea; and
School of Biological Sciences and Institute for Molecular Biology and Genetics, Seoul National University, Seoul 151-742, Korea
Submitted January 20, 2005;
Revised August 1, 2005;
Accepted August 2, 2005
Monitoring Editor: Carl-Henrik Heldin
Although Smad2 and Smad3, critical transcriptional mediators of transforming growth factor-
(TGF-
) signaling, are supposed to play a role in the TGF-
cytostatic program, it remains unclear whether TGF-
delivers cytostatic signals through both Smads equally or through either differentially. Here, we report that TGF-
cytostatic signals rely on a Smad3-, but not a Smad2-, dependent pathway and that the intensity of TGF-
cytostatic signals can be modulated by changing the endogenous ratio of Smad3 to Smad2. Depleting endogenous Smad3 by RNA interference sufficiently interfered with TGF-
cytostatic actions in various TGF-
-sensitive cell lines, whereas raising the relative endogenous ratio of Smad3 to Smad2, by depleting Smad2, markedly enhanced TGF-
cytostatic response. Consistently, Smad3 activation and its transcriptional activity upon TGF-
stimulation were facilitated in Smad2-depleted cells relative to controls. Most significantly, a single event of increasing this ratio by Smad2 depletion was sufficient to restore TGF-
cytostatic action in cells resistant to TGF-
. These findings suggest a new important determinant of sensitivity to TGF-
cytostatic signaling.
The online version of this article contains supplemental material at MBC Online (http://www.molbiolcell.org).
Address correspondence to: Yung-Jue Bang (bangyj{at}plaza.snu.ac.kr).
This article has been cited by other articles:
![]() |
X. Guo, A. Ramirez, D. S. Waddell, Z. Li, X. Liu, and X.-F. Wang Axin and GSK3- control Smad3 protein stability and modulate TGF- signaling Genes & Dev., January 1, 2008; 22(1): 106 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. V. Esguerra, L. Nelles, L. Vermeire, A. Ibrahimi, A. D. Crawford, R. Derua, E. Janssens, E. Waelkens, P. Carmeliet, D. Collen, et al. Ttrap is an essential modulator of Smad3-dependent Nodal signaling during zebrafish gastrulation and left-right axis determination Development, December 15, 2007; 134(24): 4381 - 4393. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. You, M. W. Bruinsma, T. How, J. H. Ostrander, and G. C. Blobe The type III TGF- receptor signals through both Smad3 and the p38 MAP kinase pathways to contribute to inhibition of cell proliferation Carcinogenesis, December 1, 2007; 28(12): 2491 - 2500. [Abstract] [Full Text] [PDF] |
||||